Mestastop Solutions
Unravelling metastasis biology and addressing it, for both diagnostics and discovery.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor | €0.0 Valuation: €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | $315k | Grant | |
| Total Funding | 000k | ||
Related Content
Mestastop Solutions is a pioneering company in the field of cancer research, specifically focusing on predicting the metastasis probability of primary cancer patients. Operating within the healthcare and biotechnology sectors, Mestastop serves medical professionals, oncologists, and research institutions. The company leverages its proprietary immunobiome technology to develop innovative solutions that address unmet medical needs in cancer treatment. Mestastop's business model revolves around research and development, patenting its unique technologies, and collaborating with medical experts to bring these solutions to market. Revenue is generated through partnerships, licensing agreements, and potentially direct sales of their diagnostic tools. The company recently raised Rs 1.3 crore in a seed round led by CIIE.CO, highlighting investor confidence in its groundbreaking approach. Mestastop's team comprises highly experienced professionals and eminent medical advisors, ensuring a robust foundation for its scientific endeavors.
Keywords: metastasis prediction, cancer research, immunobiome technology, oncology, healthcare innovation, proprietary platform, medical diagnostics, biotechnology, seed funding, research and development.